Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK-369,003 immediate-release/modified-release and Cialis duration-of-action study in adult men with erectile dysfunction
2004-001955-12Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of gisadenafil and tadalafil in erectile dysfunction (ED) (4 arms), sponsored by Pfizer. Primary endpoint: Primary efficacy endpoint. Started Feb 2005; status: completed.
02
Drugs
gisadenafiltadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2004-001955-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001955-12.